Literature DB >> 6652919

Glutathione synthetase deficient human fibroblasts in culture.

A Larsson, B Mattsson, L Hagenfeldt, P Moldéus.   

Abstract

Cultured skin fibroblasts from patients with 5-oxoprolinuria caused by hereditary deficiency of glutathione synthetase have decreased levels of the corresponding enzyme as well as of glutathione. Fibroblasts from the same patients accumulated gamma-glutamyl cysteine, but the levels were lower than those of glutathione in control fibroblasts. The uptake of [35S]cystine was equally rapid in control and patient fibroblasts. In the acid-soluble fraction gamma-glutamyl-[35S]cysteine accumulated in fibroblasts from patients but not from controls. Appreciable turnover of gamma-glutamyl cysteine and glutathione in the respective cell strains was observed, the half-lives of these pools being approximately 5 hours. The growth rate of mutant fibroblasts in culture was significantly slower than that of control fibroblasts. There was no significant accumulation of 5-oxoproline in the culture medium.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6652919     DOI: 10.1016/0009-8981(83)90388-1

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  A therapeutic trial with N-acetylcysteine in subjects with hereditary glutathione synthetase deficiency (5-oxoprolinuria).

Authors:  J Mårtensson; J Gustafsson; A Larsson
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

2.  Prenatal analysis in two suspected cases of glutathione synthetase deficiency.

Authors:  E Erasmus; L J Mienie; W N de Vries; W J de Wet; B Carlsson; A Larsson
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

3.  Glutathione synthetase deficiency: is gamma-glutamylcysteine accumulation a way to cope with oxidative stress in cells with insufficient levels of glutathione?

Authors:  E Ristoff; C Hebert; R Njålsson; S Norgren; O Rooyackers; A Larsson
Journal:  J Inherit Metab Dis       Date:  2002-11       Impact factor: 4.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.